Endocrine Pathology — MCQs
On this page
A 74-year-old woman is admitted to the hospital in an obtunded condition. Her temperature is 37°C, pulse is 95/min, respirations are 22/min, and blood pressure is 90/60 mm Hg. She appears dehydrated and has poor skin turgor. Her serum glucose level is 872 mg/dL. Urinalysis shows 4+ glucosuria, but no ketones, protein, or blood. Which of the following factors is most important in the pathogenesis of this patient's condition?
Which thyroid condition cannot be diagnosed by FNAC?
A 42-year-old woman presents with a 7-month history of increasing fullness in her neck. Physical examination reveals a diffusely and asymmetrically enlarged, nodular thyroid gland with no lymphadenopathy. Thyroidectomy is performed. Gross examination shows a multicentric thyroid neoplasm. Microscopically, the neoplasm is composed of polygonal-to spindle-shaped cells forming nests and trabeculae, with a prominent, pink hyaline stroma that stains positively with Congo red. Electron microscopy reveals intracytoplasmic, membrane-bound, electron-dense granules. Immunohistochemical staining for which of the following antigens is most useful for the diagnosis of this neoplasm?
All of the following are true regarding thyroid adenoma, except?
Increased urine levels of 5-HIAA are associated with which condition?
Which of the following represents a true increase in islet cells?
Zellballen pattern is seen in which of the following conditions?
Which of the following is a tumor marker for medullary thyroid carcinoma?
A surgeon operates on a patient with a pheochromocytoma involving the adrenal gland and requests intraoperative frozen sections. Which of the following criteria can be used to determine if the lesion is benign or malignant?
What is a diagnostic feature of parathyroid carcinoma?
Endocrine Pathology Indian Medical PG Practice Questions and MCQs
Question 211: A 74-year-old woman is admitted to the hospital in an obtunded condition. Her temperature is 37°C, pulse is 95/min, respirations are 22/min, and blood pressure is 90/60 mm Hg. She appears dehydrated and has poor skin turgor. Her serum glucose level is 872 mg/dL. Urinalysis shows 4+ glucosuria, but no ketones, protein, or blood. Which of the following factors is most important in the pathogenesis of this patient's condition?
- A. Autoimmune insulitis
- B. Glucokinase gene mutation
- C. HLA-DR3/HLA-DR4 genotype
- D. Peripheral insulin resistance (Correct Answer)
Explanation: ### Explanation **Diagnosis: Hyperosmolar Hyperglycemic State (HHS)** The patient presents with extreme hyperglycemia (872 mg/dL), severe dehydration (hypotension, poor turgor), and altered mental status (obtunded), but notably **lacks ketonuria**. This classic triad defines HHS, a complication typically seen in elderly patients with Type 2 Diabetes Mellitus (T2DM). **1. Why Peripheral Insulin Resistance is Correct:** The underlying pathogenesis of T2DM (and thus HHS) is **peripheral insulin resistance** coupled with a relative insulin deficiency [1]. In HHS, there is enough circulating insulin to inhibit lipolysis and prevent the formation of ketone bodies (explaining the absence of ketosis), but not enough to stimulate glucose uptake by peripheral tissues [1]. This leads to massive osmotic diuresis, profound dehydration, and extreme hyperosmolarity. **2. Why the Other Options are Incorrect:** * **A & C (Autoimmune insulitis / HLA-DR3/DR4):** These are hallmarks of **Type 1 Diabetes Mellitus (T1DM)**. T1DM typically presents in younger patients with Diabetic Ketoacidosis (DKA), characterized by positive ketones and lower glucose levels than seen here [1]. * **B (Glucokinase gene mutation):** This is the most common cause of **MODY (Maturity-Onset Diabetes of the Young)**, specifically MODY type 2. It presents as mild, stable fasting hyperglycemia in younger individuals, not as an acute hyperosmolar crisis. **3. High-Yield Clinical Pearls for NEET-PG:** * **HHS vs. DKA:** HHS has higher glucose (>600 mg/dL), higher osmolarity (>320 mOsm/L), and **no significant ketosis/acidosis** compared to DKA [1]. * **Insulin Role:** In HHS, the "trace" insulin present is sufficient to suppress hormone-sensitive lipase (preventing ketosis) but insufficient to prevent hyperglycemia [1]. * **Primary Treatment:** Aggressive fluid resuscitation (Normal Saline) is the most critical initial step in HHS management due to the massive fluid deficit (often 8–10 liters). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1114-1115.
Question 212: Which thyroid condition cannot be diagnosed by FNAC?
- A. Thyroiditis
- B. Medullary carcinoma
- C. Lymphoma
- D. Follicular carcinoma (Correct Answer)
Explanation: **Explanation:** The diagnosis of **Follicular Carcinoma** of the thyroid cannot be established by Fine Needle Aspiration Cytology (FNAC) because the distinction between a benign Follicular Adenoma and a malignant Follicular Carcinoma depends entirely on **histological evidence** of **capsular invasion** or **vascular invasion** [1]. FNAC only samples individual cells or small clusters (cytology), which cannot demonstrate the integrity of the fibrous capsule or the presence of cells within blood vessels [2]. Therefore, FNAC reports these cases as "Follicular Neoplasm," and definitive diagnosis requires surgical excision and histopathology. **Analysis of Incorrect Options:** * **A. Thyroiditis:** Conditions like Hashimoto’s thyroiditis show characteristic cytological features such as Hurthle cells and a dense lymphocytic background, making them easily diagnosable via FNAC. * **B. Medullary Carcinoma:** This tumor is identifiable by the presence of spindle-shaped or plasmacytoid cells and the presence of **amyloid** stroma (confirmed with Congo Red stain) [1]. * **C. Lymphoma:** Primary thyroid lymphoma presents with a monomorphic population of atypical lymphoid cells, which can be identified on FNAC and further categorized by flow cytometry. **High-Yield Clinical Pearls for NEET-PG:** * **Hurthle Cell Carcinoma:** Like follicular carcinoma, it also cannot be diagnosed by FNAC for the same reasons (requires evidence of invasion). * **Papillary Carcinoma:** The most common thyroid cancer; it **can** be diagnosed by FNAC due to characteristic nuclear features (Orphan Annie eyes, nuclear grooves, and Psammoma bodies) [3]. * **Bethesda System:** Used for reporting thyroid cytopathology; Follicular Neoplasm is categorized as Bethesda Category IV. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 429-431. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1100-1101. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, p. 1099.
Question 213: A 42-year-old woman presents with a 7-month history of increasing fullness in her neck. Physical examination reveals a diffusely and asymmetrically enlarged, nodular thyroid gland with no lymphadenopathy. Thyroidectomy is performed. Gross examination shows a multicentric thyroid neoplasm. Microscopically, the neoplasm is composed of polygonal-to spindle-shaped cells forming nests and trabeculae, with a prominent, pink hyaline stroma that stains positively with Congo red. Electron microscopy reveals intracytoplasmic, membrane-bound, electron-dense granules. Immunohistochemical staining for which of the following antigens is most useful for the diagnosis of this neoplasm?
- A. Calcitonin (Correct Answer)
- B. CD3
- C. Cytokeratin
- D. Estrogen receptor
Explanation: ### Explanation The clinical and pathological features described point to a diagnosis of **Medullary Thyroid Carcinoma (MTC)**. **1. Why Calcitonin is Correct:** MTC is a neuroendocrine tumor derived from the **parafollicular C-cells** of the thyroid [3]. These cells are embryologically derived from the neural crest and are responsible for secreting **calcitonin** [1]. * **Microscopy:** The "nests and trabeculae" of polygonal/spindle cells are characteristic. * **Amyloid Stroma:** The "pink hyaline stroma" that stains with **Congo red** (showing apple-green birefringence under polarized light) represents altered calcitonin fibrils (amyloid) [2]. * **Electron Microscopy:** The "membrane-bound, electron-dense granules" are typical of neuroendocrine cells containing stored hormones. * **Immunohistochemistry (IHC):** Calcitonin is the most specific and diagnostic marker for MTC [1]. **2. Why Incorrect Options are Wrong:** * **CD3:** A marker for T-lymphocytes; used in the diagnosis of lymphomas, not thyroid carcinomas. * **Cytokeratin:** While positive in most epithelial tumors (including MTC), it is non-specific and cannot differentiate MTC from other thyroid cancers or metastatic lesions. * **Estrogen Receptor (ER):** Primarily used for breast and gynecological malignancies; it has no diagnostic role in medullary thyroid pathology. **High-Yield Clinical Pearls for NEET-PG:** * **Genetic Association:** Approximately 20-25% of MTC cases are familial, associated with **RET proto-oncogene** mutations (MEN 2A and 2B syndromes) [1]. * **Tumor Marker:** Serum calcitonin levels are used for both diagnosis and monitoring postoperative recurrence [1]. * **Amyloid:** MTC is a classic example of "hormone-derived" localized amyloidosis [2]. * **IHC Profile:** MTC is also positive for **Carcinoembryonic Antigen (CEA)**, Synaptophysin, and Chromogranin [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1102-1103. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 430-431. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 428-429.
Question 214: All of the following are true regarding thyroid adenoma, except?
- A. Solitary, spherical and well encapsulated lesion
- B. Uniform-appearing, colloid-containing follicles
- C. Cystic change, calcification and Hurthle cell change
- D. Vascular invasion is commonly seen (Correct Answer)
Explanation: **Explanation:** The hallmark of **Thyroid Adenoma** (specifically Follicular Adenoma) is that it is a **benign** neoplasm. By definition, benign tumors do not exhibit invasion into surrounding structures, vessels, or the capsule [1]. **Why Option D is the Correct Answer (The False Statement):** Vascular invasion and capsular invasion are the two pathognomonic features used to distinguish **Follicular Carcinoma** from Follicular Adenoma [1], [2]. If vascular invasion is present, the diagnosis automatically shifts to malignancy. Therefore, vascular invasion is never seen in an adenoma. **Analysis of Other Options:** * **Option A:** True. Adenomas typically present as a solitary, "cold" nodule that is well-demarcated from the surrounding thyroid parenchyma by a **intact, well-defined fibrous capsule** [1], [3]. * **Option B:** True. Most adenomas consist of mature, uniform follicles containing colloid, often resembling normal thyroid tissue but separated by the capsule (Simple Adenoma) [1]. * **Option C:** True. Degenerative changes are common in larger adenomas due to outgrowing their blood supply. These include **hemorrhage, cystic change, fibrosis, and calcification** [1], [3]. **Hurthle cell change** (oxyphilic change) is also a recognized histological variant of follicular adenoma [1]. **High-Yield NEET-PG Pearls:** 1. **The Gold Standard Rule:** The distinction between Follicular Adenoma and Carcinoma **cannot** be made by FNAC (Fine Needle Aspiration Cytology) because FNAC only samples cells, not the capsule-tumor interface [1]. Histopathology is mandatory to rule out invasion. 2. **Toxic Adenoma:** A subset of adenomas can be "hot" (functional) due to somatic mutations in the TSH receptor or Gsα subunit, leading to hyperthyroidism. 3. **Clinical Presentation:** Most are solitary, painless nodules; however, any sudden increase in size usually indicates internal hemorrhage [3]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1096-1097. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1100-1101. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 428-429.
Question 215: Increased urine levels of 5-HIAA are associated with which condition?
- A. Liver Cirrhosis
- B. Papillary carcinoma of the Thyroid
- C. Carcinoid tumor (Correct Answer)
- D. Small cell carcinoma of the lung
Explanation: **Explanation:** **5-Hydroxyindoleacetic acid (5-HIAA)** is the primary end-metabolite of **Serotonin** (5-HT). The correct answer is **Carcinoid tumor**, specifically those originating from enterochromaffin (Kulchitsky) cells [1]. These neuroendocrine tumors overproduce serotonin [1]. In the liver, serotonin is metabolized by monoamine oxidase (MAO) into 5-HIAA, which is then excreted in the urine. *Note:* In primary intestinal carcinoids, 5-HIAA levels typically rise only after **liver metastasis** occurs, as the liver can no longer "clear" the serotonin before it reaches the systemic circulation (leading to Carcinoid Syndrome) [1]. **Analysis of Incorrect Options:** * **A. Liver Cirrhosis:** This involves hepatic fibrosis and does not involve serotonin overproduction. In fact, advanced cirrhosis might impair the metabolism of various amines. * **B. Papillary Carcinoma of the Thyroid:** This tumor is derived from follicular cells and is associated with Psammoma bodies and "Orphan Annie eye" nuclei, not serotonin. (Note: *Medullary* thyroid carcinoma produces Calcitonin [2]). * **D. Small Cell Carcinoma of the Lung:** While this is a neuroendocrine tumor, it is more commonly associated with ectopic hormone production like ACTH (Cushing’s) or ADH (SIADH), rather than the serotonin-driven carcinoid syndrome [3]. **High-Yield Clinical Pearls for NEET-PG:** * **Diagnostic Gold Standard:** 24-hour urinary 5-HIAA is the best initial screening test for Carcinoid Syndrome (Sensitivity ~75%). * **Dietary Interference:** Patients must avoid serotonin-rich foods (bananas, walnuts, pineapples, avocados) for 72 hours before the test to prevent false positives. * **Cardiac Involvement:** Right-sided heart valves (Tricuspid regurgitation, Pulmonary stenosis) are often affected; the left side is spared because the lungs contain MAO which degrades serotonin. * **Pellagra Link:** Chronic carcinoid can lead to **Niacin (B3) deficiency** (Pellagra) because the tumor diverts dietary Tryptophan toward Serotonin synthesis instead of Niacin. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, pp. 780-782. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 430-431. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 725-727.
Question 216: Which of the following represents a true increase in islet cells?
- A. Nesidioblastosis
- B. Type II Diabetes Mellitus (Correct Answer)
- C. Insulinoma
- D. Pancreatitis
Explanation: **Explanation:** The correct answer is **Type II Diabetes Mellitus**. In the early stages of **Type 2 Diabetes Mellitus (T2DM)**, there is a compensatory response to peripheral insulin resistance. To maintain euglycemia, the pancreas undergoes **islet cell hyperplasia**, leading to a true increase in the number and mass of beta cells [1]. However, as the disease progresses, this compensation fails, leading to amyloid deposition (amylin) and eventual beta-cell exhaustion. **Analysis of Options:** * **Nesidioblastosis:** Historically used to describe the "budding" of islet cells from ductal epithelium, it is now considered a controversial term. In adults (Non-insulinoma pancreatogenous hypoglycemia syndrome), it typically involves islet hypertrophy and disorganized growth rather than a simple "true increase" in normal islet cell distribution. * **Insulinoma:** This is a localized **neoplasm** (tumor) of the beta cells. While there is an increase in the number of cells within the tumor, it represents a neoplastic proliferation rather than a generalized physiological or compensatory increase in the pancreatic islet cell population. * **Pancreatitis:** Chronic inflammation leads to the destruction of both exocrine and endocrine components of the pancreas, resulting in **atrophy** and fibrosis of islet cells, not an increase. **High-Yield NEET-PG Pearls:** * **T2DM Pathology:** Characterized by **Amyloid (Amylin) deposition** in the islets of Langerhans in the late stages. * **T1DM Pathology:** Characterized by **Insulitis** (lymphocytic infiltration) and a marked reduction in islet mass [1]. * **Zollinger-Ellison Syndrome:** Often associated with islet cell hyperplasia (specifically G-cells) in the context of MEN-1. * **Infants of Diabetic Mothers:** These neonates show marked **islet cell hyperplasia** due to fetal exposure to maternal hyperglycemia. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, p. 1111.
Question 217: Zellballen pattern is seen in which of the following conditions?
- A. Pheochromocytoma (Correct Answer)
- B. Schwannoma
- C. Acoustic neuroma
- D. Transitional cell carcinoma
Explanation: **Explanation:** The **Zellballen pattern** is the characteristic histological hallmark of **Pheochromocytoma** (and other paragangliomas). The term "Zellballen" is German for "cell balls." It describes nests or clusters of large, pleomorphic chromaffin cells surrounded by a delicate vascular stroma and a peripheral layer of spindle-shaped **sustentacular cells** (S100 positive) [1]. **Analysis of Options:** * **A. Pheochromocytoma (Correct):** This tumor arises from the chromaffin cells of the adrenal medulla. The Zellballen architecture is highly characteristic, though it does not reliably distinguish between benign and malignant lesions [2]. * **B & C. Schwannoma / Acoustic Neuroma (Incorrect):** These are peripheral nerve sheath tumors. Histologically, they exhibit **Antoni A** (dense, hypercellular areas with Verocay bodies) and **Antoni B** (loose, hypocellular myxoid areas) patterns, not Zellballen [3]. * **D. Transitional Cell Carcinoma (Incorrect):** Also known as Urothelial Carcinoma, it typically shows papillary fronds or nests of transitional epithelium with varying degrees of nuclear atypia. **High-Yield Clinical Pearls for NEET-PG:** * **Rule of 10s:** 10% are bilateral, 10% are extra-adrenal (Paraganglioma), 10% are malignant, and 10% occur in children. * **Associated Syndromes:** MEN 2A, MEN 2B, von Hippel-Lindau (VHL), and NF-1. * **Diagnosis:** Best initial screening test is **Urinary/Plasma Metanephrines**. * **Staining:** Chromaffin cells are positive for **Chromogranin** and **Synaptophysin**; Sustentacular cells are positive for **S100** [2]. * **Electron Microscopy:** Shows characteristic "membrane-bound neurosecretory granules." **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Head and Neck, pp. 748-749. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 419-420. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Peripheral Nerves and Skeletal Muscles, p. 1250.
Question 218: Which of the following is a tumor marker for medullary thyroid carcinoma?
- A. Calcitonin
- B. CEA
- C. Serotonin
- D. All of the above (Correct Answer)
Explanation: **Explanation:** Medullary Thyroid Carcinoma (MTC) is a neuroendocrine tumor derived from the **Parafollicular C-cells** of the thyroid gland [2]. These cells are embryologically derived from the neural crest and possess the ability to secrete various hormones and peptides. * **Calcitonin (Option A):** This is the most specific and sensitive primary tumor marker for MTC [1]. It is used for diagnosis, monitoring treatment response, and detecting recurrence [2]. * **Carcinoembryonic Antigen (CEA) (Option B):** While commonly associated with GI malignancies, CEA is a highly reliable secondary marker for MTC [1]. It is particularly useful for monitoring disease progression; rising CEA levels often indicate a more aggressive clinical course or dedifferentiation. * **Serotonin (Option C):** As a neuroendocrine tumor, MTC can secrete various biogenic amines and ectopic hormones, including serotonin, ACTH, and CRH [1], [2]. Serotonin secretion can occasionally lead to clinical manifestations like flushing or diarrhea (Carcinoid-like symptoms) [2]. **Conclusion:** Since MTC cells can produce all three substances, **Option D (All of the above)** is the correct answer. **High-Yield Clinical Pearls for NEET-PG:** * **Genetics:** Approximately 25% of MTC cases are familial, associated with **RET proto-oncogene** mutations (MEN 2A and 2B) [1]. * **Histology:** Characterized by nests of polygonal cells in a fibrovascular stroma containing **Amyloid deposits** (derived from pro-calcitonin), which stain positive with **Congo Red** (Apple-green birefringence) [2]. * **Screening:** In families with known RET mutations, prophylactic thyroidectomy is often indicated based on rising serum calcitonin levels. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1102-1103. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 428-431.
Question 219: A surgeon operates on a patient with a pheochromocytoma involving the adrenal gland and requests intraoperative frozen sections. Which of the following criteria can be used to determine if the lesion is benign or malignant?
- A. Blood vessel invasion
- B. Cannot be determined by microscopic examination (Correct Answer)
- C. Hemorrhage and necrosis
- D. Nuclear pleomorphism
Explanation: **Explanation:** The diagnosis of malignancy in pheochromocytoma is unique in pathology. Unlike most tumors, malignancy **cannot be determined by microscopic examination** of the primary lesion alone [1]. **1. Why the correct answer is right:** The only definitive criterion for malignancy in pheochromocytoma is the **presence of metastases** in non-chromaffin sites (e.g., lymph nodes, liver, bone, or lungs). Histological features that typically suggest malignancy in other tumors—such as cellular atypia, necrosis, or mitotic figures—can be seen in benign pheochromocytomas [1]. Conversely, a tumor that appears histologically "bland" may still metastasize. Therefore, a frozen section or routine microscopy cannot reliably predict biological behavior. **2. Why the incorrect options are wrong:** * **Blood vessel invasion (A):** While a worrisome feature, capsular or vascular invasion can occur in tumors that never metastasize and is not a standalone proof of malignancy in pheochromocytomas. * **Hemorrhage and necrosis (C):** These are common findings in large pheochromocytomas due to their high metabolic activity and fragile vascularity; they do not correlate with malignant potential [2]. * **Nuclear pleomorphism (D):** "Endocrine atypia" (marked nuclear pleomorphism and hyperchromasia) is a common feature of many benign endocrine tumors and is not a reliable indicator of cancer. **High-Yield NEET-PG Pearls:** * **The 10% Rule:** Traditionally, 10% are malignant, 10% are bilateral, 10% are extra-adrenal (Paragangliomas), and 10% occur in children. * **PASS Score:** The *Pheochromocytoma of the Adrenal Gland Scaled Score* is used to estimate malignant potential, but clinical metastasis remains the gold standard. * **Zellballen Pattern:** The classic histological arrangement of nests of cells surrounded by sustentacular cells. * **Genetics:** Up to 25-30% are now known to be familial (associated with **RET** [MEN2], **VHL**, **NF1**, and **SDHB** mutations). SDHB mutations carry the highest risk of malignancy. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 419-420. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1137-1138.
Question 220: What is a diagnostic feature of parathyroid carcinoma?
- A. Cytology
- B. Metastasis (Correct Answer)
- C. Clinical features
- D. All of the above
Explanation: **Explanation:** The diagnosis of **parathyroid carcinoma** is notoriously difficult because many features of malignancy overlap with those of benign parathyroid adenomas. **1. Why Metastasis is the Correct Answer:** The only absolute, unequivocal criteria for diagnosing parathyroid carcinoma are **metastasis** (to regional lymph nodes or distant organs like the lungs and liver) or **direct invasion** into adjacent structures (e.g., thyroid, esophagus, or recurrent laryngeal nerve). Histological features like cellular atypia, pleomorphism, and even mitotic figures can occasionally be seen in benign adenomas (the "endocrine atypia" phenomenon), making metastasis the gold standard for a definitive diagnosis. **2. Why Other Options are Incorrect:** * **A. Cytology:** Fine-needle aspiration (FNA) is generally **contraindicated** in suspected parathyroid carcinoma. It cannot distinguish between benign and malignant cells and carries a high risk of "seeding" malignant cells along the needle track. * **C. Clinical Features:** While parathyroid carcinoma often presents with very high serum calcium (>14 mg/dL) and palpable neck masses, these are suggestive but **not diagnostic**, as severe primary hyperparathyroidism can mimic these signs. **3. High-Yield Clinical Pearls for NEET-PG:** * **Histological Clues:** While not definitive, the presence of **thick fibrous bands** (capsular) and **extensive capsular/vascular invasion** are highly suspicious [1]. * **Genetic Association:** Parathyroid carcinoma is strongly associated with mutations in the **CDC73 (formerly HRPT2) gene**, which encodes the protein **Parafibromin**. Loss of parafibromin expression is a useful IHC marker. * **Clinical Presentation:** Patients often present with "renal and bone" manifestations more severely than in adenomas. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 232-233.
Practice by Chapter
Pituitary Gland Disorders
Practice Questions
Thyroid Gland Diseases
Practice Questions
Parathyroid Gland Pathology
Practice Questions
Adrenal Cortical Disorders
Practice Questions
Adrenal Medullary Disorders
Practice Questions
Pancreatic Endocrine Disorders
Practice Questions
Multiple Endocrine Neoplasia Syndromes
Practice Questions
Diffuse Neuroendocrine System
Practice Questions
Pineal Gland Pathology
Practice Questions
Laboratory Diagnosis of Endocrine Diseases
Practice Questions
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free